In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study
- PMID: 15806130
- DOI: 10.1038/sj.bmt.1704940
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
